Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00500838 · ClinicalTrials.gov registry record · NA
Cardiac Resynchronization Therapy Defibrillator Based Impedance Monitoring Study
A NA study of Heart Failure, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 4
- Study locations
NCT00500838: Completed NA study of Heart Failure, sponsored by Abbott Medical Devices.
NCT00500838 is a NA study of Heart Failure that has completed, run by Abbott Medical Devices. The registered enrollment target is 75 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (96% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00500838, a NA study of Heart Failure, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 4
- Study locations
Study Summary
The intent of this feasibility study is to collect and analyze intra-thoracic impedance measurements from a CRT-D device in a heart failure population.
Conditions Studied
Interventions
- DEVICE Transthoracic Impedance
Study Locations (4)
Arkansas
- Baptist Health Medical Center - Little Rock
California
- Glendale Memorial Hospital - Glendale
New Jersey
- Deborah Heart and Lung - Browns Mills
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-08 |
| Phase | NA |
What the finished NCT00500838 record still lists
NCT00500838 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Transthoracic Impedance is the first listed.
NCT00500838 reports a single indexed study location in Arkansas, California, New Jersey.
Frequently Asked Questions
What is clinical trial NCT00500838 about?
NCT00500838 is a clinical study titled "Cardiac Resynchronization Therapy Defibrillator Based Impedance Monitoring Study". The intent of this feasibility study is to collect and analyze intra-thoracic impedance measurements from a CRT-D device in a heart failure population.
What is the current status of trial NCT00500838?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2007-07. Estimated completion is 2008-08.
What conditions does trial NCT00500838 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT00500838?
The interventions under investigation include: Transthoracic Impedance (DEVICE).
Who is sponsoring clinical trial NCT00500838?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00500838 being conducted?
This trial has 4 study locations across Arkansas, California, New Jersey, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00500838's enrollment target sits among peer trials
75 233rd of 397 higher than 161 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia